CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South‐East and East Asian populations: A systematic review

PW Dorji, G Tshering… - Journal of clinical …, 2019 - Wiley Online Library
What is known and objective Genetic polymorphism is one of the most important factors
responsible for interindividual and interethnic variability in drug response. Studies in major …

[HTML][HTML] Tratamiento de cáncer de seno y farmacogenética

YV Ariza Márquez, I Briceño Balcázar… - Revista Colombiana …, 2016 - scielo.org.co
El cáncer de seno es un grupo de enfermedades con gran impacto a nivel mundial dado
que es una de las patologías con mayor prevalencia en mujeres y el cáncer con mayor tasa …

Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population

L Ganoci, T Božina, N Mirošević Skvrce… - Drug metabolism and …, 2017 - degruyter.com
Background: Data on the frequency of pharmacogenetic polymorphisms in the Croatian
population are limited. We determined and analyzed frequencies for the most important …

Single nucleotide and structural variants of CYP2D6 gene in Kinh Vietnamese population

HH Nguyen, TTH Ma, NP Vu, QTN Bach, TH Vu… - Medicine, 2019 - journals.lww.com
Single nucleotide and structural variants of CYP2D6 gene in... : Medicine Single nucleotide
and structural variants of CYP2D6 gene in Kinh Vietnamese population : Medicine Log in or …

The Diversity of CYP2C19 Polymorphisms in the Thai Population: Implications for Precision Medicine

V Nakhonsri, S John, H Panumasmontol… - The Application of …, 2024 - Taylor & Francis
Introduction CYP2C19 plays a major role in the metabolism of various drugs. The most
common genetic variants were the CYP2C19* 2 and* 3 alleles (rs4244285 and rs4986893 …

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder

S Medhasi, E Pasomsub, N Vanwong… - Neuropsychiatric …, 2016 - Taylor & Francis
Single-nucleotide polymorphisms (SNPs) among drug-metabolizing enzymes and
transporters (DMETs) influence the pharmacokinetic profile of drugs and exhibit intra-and …

Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population

PW Dorji, S Wangchuk, K Boonprasert… - Drug Metabolism and …, 2019 - degruyter.com
Background Marked differences among genotype frequencies (Caucasians, Asians, and
Africans) have been observed in cytochrome P450 (CYP) genes. Data on the frequency of …

promoter genotype: Diagnostic and population pharmacogenetic marker in Serbia

M Vukovic, N Radlovic, Z Lekovic… - Balkan Journal of …, 2018 - sciendo.com
The UGT1A1 enzyme is involved in the metabolism of bilirubin and numerous medications.
Unconjugated hyperbilirubinemia, commonly presented as Gilbert syndrome (GS), is a result …

Older hypertensive patients' adherence to healthy lifestyle behaviors

M Andjelkovic, M Mitrovic, I Nikolic… - Experimental and …, 2018 - sciendo.com
Non-pharmacological treatment including diet, body weight reduction, smoking cessation
and physical activity, is very important part of hypertension treatment. The objective of this …

Genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in Kosovar population

V Krasniqi, A Dimovski, H Qorraj Bytyqi… - Arhiv za higijenu rada i …, 2017 - hrcak.srce.hr
Sažetak Cytochrome P450 genetic polymorphisms are responsible for individual variations
in drug metabolism and drug-drug interactions. They are very important for …